Premium
Clinical care of pregnant and postpartum women with COVID‐19: Living recommendations from the National COVID‐19 Clinical Evidence Taskforce
Author(s) -
Vogel Joshua P.,
Tendal Britta,
Giles Michelle,
Whitehead Clare,
Burton Wendy,
Chakraborty Samantha,
Cheyne Saskia,
Downton Teena,
Fraile Navarro David,
Gleeson Glenda,
Gordon Adrienne,
Hunt Jenny,
Kitschke Jackie,
McDonald Steven,
McDonnell Nolan,
Middleton Philippa,
Millard Tanya,
Murano Melissa,
Oats Jeremy,
Tate Rhian,
White Heath,
Elliott Julian,
Roach Vijay,
Homer Caroline S.E.
Publication year - 2020
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/ajo.13270
Subject(s) - medicine , extracorporeal membrane oxygenation , hydroxychloroquine , intensive care medicine , covid-19 , breastfeeding , pregnancy , obstetrics , disease , pediatrics , infectious disease (medical specialty) , biology , genetics
To date, 18 living recommendations for the clinical care of pregnant and postpartum women with COVID-19 have been issued by the National COVID-19 Clinical Evidence Taskforce. This includes recommendations on mode of birth, delayed umbilical cord clamping, skin-to-skin contact, breastfeeding, rooming-in, antenatal corticosteroids, angiotensin-converting enzyme inhibitors, disease-modifying treatments (including dexamethasone, remdesivir and hydroxychloroquine), venous thromboembolism prophylaxis and advanced respiratory support interventions (prone positioning and extracorporeal membrane oxygenation). Through continuous evidence surveillance, these living recommendations are updated in near real-time to ensure clinicians in Australia have reliable, evidence-based guidelines for clinical decision-making. Please visit https://covid19evidence.net.au/ for the latest recommendation updates.